Patent directory · USPTO A61K / A61P
Patents matching “Sangamo Therapeutics, Inc.”
106 pharma patents match "Sangamo Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 106 pharmaceutical patents matching "Sangamo Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10435441
HTT repressors and uses thereof
granted -
US 10407476
Methods and compositions for treating hemophilia
granted -
US 10370680
Method of treating factor IX deficiency using nuclease-mediated targeted integration
granted -
US 10369201
Methods and compositions for treating Huntington's disease
granted -
US 10344271
Modified zinc finger binding proteins
granted -
US 10293000
Methods and compositions for the treatment of lysosomal storage diseases
granted -
US 10265377
Methods and compositions for treating Huntington's Disease
granted -
US 10253333
DNA-binding proteins and uses thereof
granted -
US 10227610
Methods and compositions for enhancing nuclease-mediated gene disruption
granted -
US 10155011
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted -
US 10143760
Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
granted -
US 10117899
Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
granted -
US 10113207
Methods and compositions for targeted single-stranded cleavage and targeted integration
granted -
US 10081661
Methods and compositions for genome engineering
granted -
US 10072066
Methods and compositions for treatment of a beta thalessemia
granted -
US 10046028
Methods and compositions for modulating PD1
granted -
US 9982245
Compositions for linking DNA-binding domains and cleavage domains
granted -
US 9963715
Methods and compositions for treatment of a genetic condition
granted -
US 9956247
Method of treating lysosomal storage diseases
granted -
US 9957501
Nuclease-mediated regulation of gene expression
granted -
US 9957526
Delivery methods and compositions for nuclease-mediated genome engineering
granted -
US 9943565
Methods and compositions for treating trinucleotide repeat disorders
granted -
US 9937207
Targeted disruption of T cell receptor genes using talens
granted -
US 9914940
Targeted integration into the PPP1R12C locus
granted